FDA Approves First Fentanyl Nasal Spray for Breakthrough Cancer Pain
Links shared publicly online about this topic.
- 151total visits
FDA Approves First Fentanyl Nasal Spray for Breakthrough Cancer Pain
View full resource at onclive.com
Tags: Pain, Cancer, Cancer Pain Medication, Nose, FDA, Duragesic, Actiq
Most Recently Shared on January 1, 2012 at 2:30 am By:
2011 Review: Multiple approvals for Supportive Care - notable the First Fentanyl Nasal Spray - Lazanda http://t.co/J4GaboCv
Medical News: FDA Okays Nasal Spray for Ca Pain - in Public Health & Policy, FDA General from MedPage Today
medpagetoday.com — “WASHINGTON -- The FDA has approved a nasal spray formulation of the drug fentanyl (Lazanda) to manage breakthrough pain in cancer patients 18 and older who are already using opioid therapy.” View full resource at medpagetoday.com
Most Recently Shared on July 5, 2011 at 4:51 pm By:
New nasal spray to treat pain in cancer patients is approved by the #FDA http://bit.ly/k9MyZr
Nycomed's Instanyl (Fentanyl) Single-Dose Nasal Spray Receives European Approval - QualityPoint Technologies
qualitypointtech.net — “Nycomed today announced that the European Commission has granted marketing authorisation for its Instanyl single-dose nasal spray. The single-dose nasal spray marks another innovation by Nycomed in the management of breakthrough pain in cancer patients and will be available in European countries from September 2011. Instanyl fentanyl nasal spray has been developed by Nycomed. It was the first fast acting nasal opioid approved for the management of breakthrough pain in cancer patients, and was fi” View full resource at qualitypointtech.net
Most Recently Shared on July 4, 2011 at 12:00 pm By:
Nycomed's Instanyl (Fentanyl) Single-Dose Nasal Spray Receives European Approval: Nycomed today announced that th... http://bit.ly/lI5vFW
Medical News: FDA Okays Nasal Spray for Ca Pain - in Public Health & Policy, FDA General from MedPage Today
medpagetoday.com — “WASHINGTON -- The FDA has approved a nasal spray formulation of the drug fentanyl (Lazanda) to manage breakthrough pain in cancer patients 18 and older who are already using opioid therapy.” View full resource at medpagetoday.com
Most Recently Shared on July 2, 2011 at 1:47 pm By:
Patricia Grace Eldercare Expert
FDA Okays Nasal Spray for Ca Pain: WASHINGTON (MedPage Today) -- The FDA has approved a nasal spray formulation ... http://bit.ly/iWcUVq
FDA Okays Nasal Spray for Ca Pain - QualityPoint Technologies
qualitypointtech.net — “WASHINGTON (MedPage Today) -- The FDA has approved a nasal spray formulation of the drug fentanyl (Lazanda) to manage breakthrough pain in cancer patients 18 and older who are already using opioid therapy.” View full resource at qualitypointtech.net
Most Recently Shared on July 2, 2011 at 1:45 pm By:
FDA Okays Nasal Spray for Ca Pain: WASHINGTON (MedPage Today) -- The FDA has approved a nasal spray formulation of... http://bit.ly/mpdinQ
Medical News: FDA Okays Nasal Spray for Ca Pain - in Public Health & Policy, FDA General from MedPage Today
medpagetoday.com — “WASHINGTON -- The FDA has approved a nasal spray formulation of the drug fentanyl (Lazanda) to manage breakthrough pain in cancer patients 18 and older who are already using opioid therapy.” View full resource at medpagetoday.com
Most Recently Shared on July 2, 2011 at 1:27 pm By:
FDA Okays Nasal Spray for Ca Pain http://bit.ly/l97juH
Medical News: FDA Okays Nasal Spray for Ca Pain - in Public Health & Policy, FDA General from MedPage Today
medpagetoday.com — “WASHINGTON -- The FDA has approved a nasal spray formulation of the drug fentanyl (Lazanda) to manage breakthrough pain in cancer patients 18 and older who are already using opioid therapy.” View full resource at medpagetoday.com
Most Recently Shared on July 2, 2011 at 1:16 pm By:
FDA Okays Nasal Spray for Ca Pain http://bit.ly/j6KrSw
Lazanda Approved for Breakthrough Cancer Pain - ONA
oncologynurseadvisor.com — “Archimedes Pharma U.S. Inc. announced that the FDA has approved Lazanda (fentanyl) nasal spray for the management of breakthrough pain in cancer patients ?18 years who are already receiving and are tolerant to opioid therapy for their underlying persistent cancer pain.” View full resource at oncologynurseadvisor.com
Most Recently Shared on July 1, 2011 at 1:57 pm By:
OncologyNurseAdvisor Medical Education, Medical Publisher, Oncology, and Nursing
Lazanda Approved for Breakthrough Cancer Pain http://goo.gl/fb/koVKh
FDA Approves Lazanda® - First Fentanyl Nasal Spray - For The Management Of Breakthrough Pain In Cancer Patients
medicalnewstoday.com — “Archimedes Pharma Ltd., and its subsidiary, Archimedes Pharma U.S. Inc., announced that the U.S. Food and Drug Administration (FDA) has approved Lazanda® (fentanyl) nasal spray for the managem” View full resource at medicalnewstoday.com
Most Recently Shared on July 1, 2011 at 8:05 am By:
FDA Approves Lazanda® - First Fentanyl Nasal Spray - For The Management Of Breakthrough Pain In Cancer Patients http://mnt.to/3XSk
FDA Approves First Fentanyl Nasal Spray for Cancer Pain - QualityPoint Technologies
qualitypointtech.net — “The FDA has approved the first fentanyl nasal spray to treat breakthrough pain in cancer patients who are opioid tolerant. Medscape Medical News” View full resource at qualitypointtech.net
Most Recently Shared on July 1, 2011 at 1:45 am By:
FDA Approves First Fentanyl Nasal Spray for Cancer Pain: The FDA has approved the first fentanyl nasal spray to tr... http://bit.ly/jQEYgl
FDA Approves Lazanda - First Fentanyl Nasal Spray - for the Management of Breakthrough Pain in Cancer Patients
drugs.com — “Lazanda (fentanyl) nasal spray is used to treat breakthrough pain in cancer patients. Includes Lazanda side effects, interactions and indications.” View full resource at drugs.com
Most Recently Shared on July 1, 2011 at 1:08 am By:
Drugs and Devices OW OW Health
FDA Approves Lazanda - First Fentanyl Nasal Spray - for the Management of Breakthrough Pain in Cancer Pati... http://bit.ly/mxmtJE #drug
FDA Approves Lazanda (Fentanyl) Nasal Spray for Breakthrough Cancer Pain
disabled-world.com — “FDA approved Lazanda (fentanyl) nasal spray for management of breakthrough pain in cancer patients 18 years and older already receiving and are tolerant to opioid therapy for underlying persistent cancer pain” View full resource at disabled-world.com
Most Recently Shared on June 30, 2011 at 11:03 pm By:
Disabled World Health Advocate and Health News
FDA Approves Lazanda (Fentanyl) Nasal Spray for Breakthrough Cancer Pain http://ff.im/-H07aY
Advertisement
